Chi Li
General Counsel chez EDITAS MEDICINE, INC.
Profil
Chi Li is currently the Chief Regulatory Officer & Senior Vice President at Editas Medicine, Inc. Prior to this, he worked as the Chief Regulatory Officer at Celularity, Inc. Dr. Li holds a doctorate degree from Purdue University and an MBA from Rutgers University, Camden.
Postes actifs de Chi Li
| Sociétés | Poste | Début |
|---|---|---|
| EDITAS MEDICINE, INC. | General Counsel | 14/06/2021 |
Anciens postes connus de Chi Li
| Sociétés | Poste | Fin |
|---|---|---|
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | General Counsel | - |
Formation de Chi Li
| Purdue University | Doctorate Degree |
| Rutgers University, Camden | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EDITAS MEDICINE, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Celularity, Inc. (United States)
Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Commercial Services |
